| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.7M | +11.7% |
| R&D Expense | $3.7M | +78.0% |
| SG&A Expense | $37.8M | +11.7% |
| Operating Income | -$11.3M | +34.1% |
| Pre-tax Income | -$10.5M | +40.7% |
| Income Tax | $25K | +13.6% |
| Net Income | -$10.5M | +40.7% |
| EPS (Basic) | -$1.04 | +67.7% |
| EPS (Diluted) | -$1.04 | +67.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.4M | +8.2% |
| Inventory | $1.4M | -78.5% |
| Current Assets | $18.1M | -12.6% |
| Total Assets | $28.6M | +29.2% |
| Current Liabilities | $11.9M | -1.0% |
| Total Liabilities | $18.1M | +2.4% |
| Stockholders' Equity | $10.5M | +136.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.4M | -30.1% |
| Capital Expenditures | $2K | -80.0% |
| Investing Cash Flow | $3.0M | — |
| Financing Cash Flow | $10.8M | -26.9% |
| Free Cash Flow | -$13.4M | -30.0% |